Overall, decreased levels of TNF-α, IL-1β, IFN-γ, IL-2, and IL-12 in plasma from T2DM individuals will lead to the failed formation of the granuloma, decreased NO release, diminished activation of macrophages, and weakened T-cell activity. The gene discussed is IL1B; the disease is type 2 diabetes mellitus.